Concepedia

Sheryl Trueman

ST

6

Publications

149

Citations

6

H-Index

2014

Active since

Affiliations

AbbVie (United States)(Current)

Orlando Clinical Research Center

Sheryl Trueman is an author at AbbVie (United States) specializing in chemodynamic therapy, bioimaging, and tumor biology.

Top concepts

Publications per year

2014–2019

6

Publications

6

Characterization of the Effect of Renal Impairment on Upadacitinib Pharmacokinetics

Mohamed‐Eslam F. Mohamed, Sheryl Trueman, Feng Tian et al. · The Journal of Clinical Pharmacology · 2019 · 44 citations · Full text

Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation

Mohamed‐Eslam F. Mohamed, Sheryl Trueman, Mohamed I. A. Othman et al. · The AAPS Journal · 2019 · 37 citations · Full text

Characterization of the Effect of Hepatic Impairment on Upadacitinib Pharmacokinetics

Sheryl Trueman, Mohamed‐Eslam F. Mohamed, Feng Tian et al. · The Journal of Clinical Pharmacology · 2019 · 28 citations · Full text

The JAK1 Inhibitor Upadacitinib Has No Effect on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol: A Study in Healthy Female Subjects

Mohamed‐Eslam F. Mohamed, Sheryl Trueman, Feng Tian et al. · The Journal of Clinical Pharmacology · 2018 · 17 citations · Full text

Abstract 2065: Magnetic resonance imaging with an iron oxide nanoparticle demonstrates the preclinical feasibility of predicting intratumoral uptake and activity of MM-398, a nanoliposomal irinotecan (nal-IRI)

Ashish Kalra, Joseph A. Spernyak, Jaeyeon Kim et al. · Cancer Research · 2014 · 13 citations

, , +24

Rows per page

1–5 of 6